GHRP-2 Dosing & Reconstitution Guide
Dosing Protocol
Route: Subcutaneous Frequency: 2–3 times daily Dose Range: 100–300 mcg per injection, 2–3x daily Cycle Length: 8–12 weeks on, 4 weeks off Timing: On empty stomach; best before meals and before bed
Reconstitution
Vial Size: 5mg Water Volume: 2.5mL Concentration: 2mg/mL
Titration Schedule
Weeks 1–2: 100 mcg 2x daily Weeks 3+: 200–300 mcg 2–3x daily
Timeline & Pharmacokinetics
Onset: 15–30 minutes Peak Plasma: 15–60 minutes (GH peak ~15–30 min post-injection) Half-Life: ~25–30 minutes Steady State: 2–4 weeks of daily dosing Time to Results: 2–4 weeks for sleep improvement; 8–12 weeks for body composition Washout: 1–2 weeks
Storage
Lyophilized: −20 °C (−4 °F) Reconstituted: 2–8 °C (35.6–46.4 °F) Shelf Life: 28 days
Injection Sites
Abdomen, Thigh
Safety & Contraindications
Safety: Well tolerated in clinical trials with placebo-like safety profile at therapeutic ranges May increase appetite (less than GHRP-6) Can elevate cortisol and prolactin levels (less than GHRP-6)
Contraindications: Active malignancy (GH/IGF-1 elevation contraindicated); Pregnancy and breastfeeding; Pituitary disorders (outside diagnostic context)